iTBS Effect on M1 Plasticity, Blood Glucose, and Cardiovascular Response

NCT ID: NCT06043076

Last Updated: 2024-04-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-01

Study Completion Date

2024-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Transcranial magnetic stimulation is a medical device that can alter motor cortical (M1) excitability through the scalp via various protocols. Among these, intermittent theta-burst stimulation (iTBS) is a novel protocol that enhances the M1 excitability for several minutes beyond stimulation. The changes in M1 excitability might in turn be accompanied by other physiological responses in the human body. This study will explore the effect of iTBS protocol on M1 plasticity, heart rate, blood pressure, and blood glucose in healthy young adults in comparison to sham stimulation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Young Adults

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active then sham stimulation

Active iTBS over the left M1 hand region, followed after 1 week washout period by sham iTBS over the left M1 hand region

Group Type EXPERIMENTAL

TMS

Intervention Type DEVICE

Active iTBS will be applied using a butterfly figure-of-eight C-B60 coil connected to MagPro R30 stimulator with add-on Theta Burst option (MagVenture A/S, Farum, Denmark).

Sham

Intervention Type DEVICE

Sham iTBS will be applied using acoustic stimulation of a second coil behind the participant's head

Sham then active stimulation

Sham iTBS over the left M1 hand region, followed after 1 week washout period by active iTBS over the left M1 hand region

Group Type EXPERIMENTAL

TMS

Intervention Type DEVICE

Active iTBS will be applied using a butterfly figure-of-eight C-B60 coil connected to MagPro R30 stimulator with add-on Theta Burst option (MagVenture A/S, Farum, Denmark).

Sham

Intervention Type DEVICE

Sham iTBS will be applied using acoustic stimulation of a second coil behind the participant's head

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TMS

Active iTBS will be applied using a butterfly figure-of-eight C-B60 coil connected to MagPro R30 stimulator with add-on Theta Burst option (MagVenture A/S, Farum, Denmark).

Intervention Type DEVICE

Sham

Sham iTBS will be applied using acoustic stimulation of a second coil behind the participant's head

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy young adults (18-35 years old)
* Right-handed
* Fully vaccinated against COVID-19

Exclusion Criteria

* Subjects with contraindications to TMS based on the screening 13-item questionnaire for TMS candidacy
* Smokers
* Obese (BMI ≥ 30)
* Highly active subjects
* Active or previous lab-confirmed COVID-19 with long symptoms
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universiti Putra Malaysia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Wan Aliaa Wan Sulaiman

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Sultan Abdul Aziz Shah

Serdang, Selangor, Malaysia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Malaysia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JKEUPM-2023-674

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

iTBS Methods and Motor Cortex Excitability
NCT03584438 COMPLETED EARLY_PHASE1
Prefrontal iTBS on Working Memory
NCT05774223 COMPLETED NA
Optimization of ITBS for Depression
NCT06464445 RECRUITING NA
ITBS in MCI and Mild AD
NCT06670820 NOT_YET_RECRUITING NA